B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
10 clinical trials · Condition
◉ Watch B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
| Record | Firm | Date |
|---|---|---|
| Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia (NCT03739814) | National Cancer Institute (NCI) | 2019-05-08 |
| Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia (NCT03488225) | M.D. Anderson Cancer Center | 2018-03-28 |
| Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (NCT02484430) | National Cancer Institute (NCI) | 2017-04-06 |
| Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia (NCT02003222) | National Cancer Institute (NCI) | 2014-05-19 |
| Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT01371630) | M.D. Anderson Cancer Center | 2011-08-26 |
Track B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative automatically
Every clearance here is in the API, with alerts when new ones post.